Journal of Clinical and Experimental Ophthalmology
Open Access
ISSN: 2155-9570
ISSN: 2155-9570
Sherif Amer
Neuro-Ophthalmologist, Egypt
Posters & Accepted Abstracts: J Clin Exp Ophthalmol
Purpose: The aim of this work is to determine the effective dose of acetazolamide on visual recovery in cases of pseudotumor cerebri (PTC) in initial presentation and follow up using a new papilledema grading and scoring system. Subjects & Methods: Cases on medical therapy of papilledema referred for neuro-ophthalmic consultation were included in the study. Newly presenting cases were categorized as group 1 and follow up cases were included in group 2. Fifty seven cases of papilledema were included in the study. Group 1 included 23 cases of newly diagnosed as PTC while group 2 included 34 follow up cases under variable doses of acetazolamide. The study included 4 males and 53 females. Age ranges from 12 years to 52 years of age. Follow up ranged from 6 to 32 months. Results: Papilledema grading and scoring system was used in the initial dose calculation and dose modification in the 2 groups of patients. Dose calculation and modification was successful in stabilization of visual deterioration in 51 cases with only 6 cases referred for surgery. Two cases had optic nerve sheath decompression while 2 cases had lumboperitoneal shunts with another 2 cases having both surgery performed at different occasions. Conclusion: New papilledema grading and scoring system provides an effective, reliable, and reproducible method in dose calculation of acetazolamide in both new and follow up presentations. A proper dose calculation is a safeguard against progressive irreversible visual in PTC patients.
Email: sherif_kamel_1999@yahoo.com